Helen Palmer

Researchers at Duke University are testing a new cancer treatment method that involves sending in tiny little fat balloons loaded with drugs. Helen Palmer reports.

Food from cloned animals poses no risk, so warning labels aren't justified, according to the FDA. Still, consumers don't seem to have an appetite for it. Helen Palmer reports.

As the Medicare drug plan reenrollment deadline fast approaches, a new glitch is causing problems for many seniors. Helen Palmer reports.

VaxGen fails to meet deadlines and loses $900 million deal with the U.S. And, it's not just the vaccine that's in trouble but the whole bio-defense program it's part of, Project Bioshield. Helen Palmer reports.

There's already a safety warning for children, but today an FDA panel looks at whether labeling on antidepressants should include increased risk of suicide for adults too. Helen Palmer reports.

The U.S. will spend around $2 trillion on health care this year. And, Helen Palmer discovers, nearly a third of that cash is devoted to hospitals.

Drug-coated stents used to prop open clogged arteries have some big advantages, but studies suggest they could carry dangerous risks too. Helen Palmer reports.

Pfizer halted development of its new cholesterol drug following unexpected deaths during test trials. It's a huge blow to the drugmaker, which needs a blockbuster with Lipitor's patent set to expire in 5 years. Helen Palmer reports.

The nation's largest drugstore chains say they're working to improve patient privacy after an investigative reporter easily found sensitive information about their customers.

Pfizer has announced that it will slash 20 percent of its workforce. The company's plagued by an industry-wide problem, as drug reps find it harder and harder to get face time with doctors. Helen Palmer reports.